VJOncology is committed to improving our service to you

ASCO 2018 | Prostate cancer updates from ASCO 2018

VJOncology is committed to improving our service to you

Neal Shore

Promising genitourinary cancer updates were presented at the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL. Neal Shore, MD, of Carolina Urologic Research Center, Myrtle Beach, SC, gives his top picks for advanced prostate cancer here. For metastatic castration-resistant prostate cancer (mCRPC), Dr Shore highlights updates in: the combination of olaparib with abiraterone (NCT01972217); pembrolizumab plus enzalutamide (NCT02312557); different dosing regimens of radium-223 (NCT02023697); and radiolabelled PSMA ligands for theranostics (12615000912583).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter